ISPO

Immunotherapy

Dendritic cell phenotype induced in the peripheral blood of patients with cutaneous T cell lymphoma after photopheresis

C L Berger PhD , C Lee BS , R L Edelson MD

Combinatorial biology: generation of human recombinant antibodies against tumor antigens

B Krebs A Knappik , A Hoess , B Virnekaes , C Rothe , G Wellnhofer , J Woelle , L Ge , P Pack , R Schier , S Reif

Lactadherin, a novel cell adhesion molecule as a target for radioimmunotherapy of breast cancer

JA Peterson PhD, C Scallan PhD, EW Blank MS, RL Ceriani MD PhD

Responsiveness of prostate carcinoma bone and prostate tumors to Interleukin 2 therapy

GG Hillman PhD, J Triest MD, DJ Grignon MD, CY Wang PhD, RL Maughan PhD, ML Cher MD, JE Pontes MD, JD Forman, SV Kocher

P-glycoprotein mediated multidrug resistance: possibility to overcome it by polymer conjugated drugs targeted by different antibodies

M Stastný, M Jelínkovà, J Strohalm , D Plocovà , K Ulbrich , B Øíhovà

Murine mammary carcinoma: Control and treatment of primary and metastatic tumors

S. Baskar, PhD

Possible participation of platelet-activating factor in tumor promoter-induced TNF-α production

K Ohuchi PhD, M Yamada PhD, S Mue MD

High-dose radioimmunotherapy for metastatic breast cancer with Y-90-huBrE-3: A phase I study with autologous stem cell support (ASCS)

PJ Cagnoni, MD, RL Ceriani, MD PhD, W Cole, PhD, T Johnson, PhD, R Quaife, MD, Y Nieto, MD, SM Matthes, BS, EJ Shpall, MD, SI Bearman, MD(

Cell surface CD44 activation of lymphoma cells is associated with the synergistic effect of phorbol ester-dependent signaling and receptor deglycosylation

M Rochman, J Moll PhD, P Herrlich PhD, B Wallach, S Nedvetzki, R Vogt Sionov PhD, I Golan PhD, D Ish-Shalom PhD and D Naor PhD (1

Spontaneous or interferon-g induced T-cell infitration, HLA-DR and ICAM-1 expression in condylomas are associated with TH1 or mixed TH1/TH2 cytokine mRNA expression profiles

A Grassegger MD, I Rollinger-Holzinger MD , B. Zelger MD , K Heim MD , H Zwierzina MD , P. Fritsch MD , R Hoepfl MD

Simplified bovine leukemia virus derivatives that lack regulatory genes are potential retroviral preventive vaccines

C Altaner PhD DSc, L Kucerova MSc , V Altanerova PhD , K Boris-Lawrie PhD

Production of a synthetic general cancer vaccine which augments the concentration of antimalignin antibody in vivo

S Bogoch MD PhD , ES Bogoch MD

Cellular vaccines protect against T lymphoma through a CD8 response to class I tumor antigens potentially derived from the T cell receptor

CL Berger Ph D , D Hanlon Ph D , M Girardi MD , X.Dong MD , S Yang MD , RL Edelson MD .

Vaccination with recombinant Vaccinia virus expressing HPV16 E7 targeted to endoplasmic reticulum or with tumor cells infected with Vaccinia virus expressing GM-CSF

S Nemeckova PhD , L Kutinova PhD , R Stranska , P Gabriel , E Sobotkova PhD , M Smahel , V Vonka MD

Studies on the humoral immune response to hemagglutinin and neuraminidase of influenza vaccine in children with acute lymphoblastic leukemia

LB Brydak Ph D Assoc Prof , R Rokicka-Milewska MD Prof , M Machala MSc , T Jackowska MD

Synergistic effects of Actinobacillus suis cells, commensal bacteria, in combination with 5-fluorouracil on incidence of murine L1210 leukemia

T Watanabe PhD

Antibodies to procathepsin L reduce the malignant potential of myeloma cells

E Weber MD , D Günther

IFN-Y and IL-2 induce modulation of some, surface antigens in HIV-1 target leukemic cells

Gennero L , Barilaro MR , Martini C , Piragino A , Micolo O , Pescarmona GP & Pugliese A

MRN-100 depletes glutathione level and increases human head & neck carcinoma Calu-27 sensitivity to natural killer cell cytotoxicity

M Ghoneum PhD, M Al-Bassam PhD

Serum thrombopoietin concentrations in patients receiving peripheral blood stem cell transplantation with activated natural killer cells and interleukin-2

YG Meng PhD, J Lister MD

Effect of a recombinant lectin, Viscum album agglutinin (rVAA) on secretion of interleukin-12 in cultured human peripheral blood mononuclear cells and on NK cell-mediated cytotoxicity of rat splenocytes in vitro and in in vivo

T Hajto MD , K Hostanska PhD , K Weber PhD , H Zinke PhD , J Fischer PhD , U Mengs PhD , H Lentzen PhD , R Saller MD

Pharmacokinetics of intravenous recombinant human Granulocyte Colony-Stimulating Factor (rhG-CSF) in children receiving myelosuppressive cancer chemotherapy

MG Sturgill PharmD , RD Huhn MD , RA Drachtman MD , AG Ettinger BSN , LJ Ettinger MD

Combination immunotherapy with OK-432, recombinant granulocyte colony-stimulating factor and recombinant interleukin-2 for human hepato-cellular carcinoma

T Himoto , S Watanabe , M Nishioka ,T Maeba , S Tanaka , M Saito

Bacillus Calmette-Guerin inhibition of urinary bladder tumor development in rats pretreated with N-butyl-N-(4-hydoxybutyl)nitrosamine: Histopatho-logical and p-53, bcl-2 and PCNA immunohisto-chemical findings

T Okamura MD PhD , H Tatsura MD , Y Ito MD , K Tozawa MD PhD , and K Kohri MD PhD

Intravesical bacillus Calmette-Guerin in stage T1 grade 3 bladder cancer therapy: A 7-year follow-up

R Hurle MD, A Losa MD, E Micheli MD, A Lembo MD

Specific antitumor immune response induced by MHC class II genes transfection in B7 (CD80, CD86) negative leukemic cells

Claudia Mongini PhD, María José Gravisaco PhD student, Mariano Sànchez Lockhart PhD student, Claudia Waldner PhD, Elida Alvarez PhD & Silvia Hajos PhD

Adjuvant autolymphocyte therapy in T 1-3a,b,c or T 4N+M0 renal cell cancer

I Sawczuk, S Armentrout , R Babayan , S Graham, Jr , S Holden , J Klarnet , T Kuzel , S Leong , J A. Smith, Jr. , and C White <

Efficacy of CTL therapy on malignant tumors as a tumor specific immunotherapy in humans (REV 1 7/27/98)

S Fujimoto MD PhD, S Hamasato MD, K Araki MD PhD, Y Noguchi MD, H Miyazawa BA

A Tumor-specific Th2 clone involved in tumor rejection via primed CD8+ cytotoxic T lymphocyte (CTL) activation in mice

Y Shen Md PhD, S Fujimoto MD PhD

A novel monoclonal antibody JT-95 specifically reacts with sialyl fibronectin of thyroid carcinoma

H Takeyama MD, T Hosoya MD, N Shinozaki MD, K Uchida MD, H Shioya MD, T Ohno MD PhD, Y Yamazaki MD , N Kimura PhD

SMO47, a monoclonal antibody to a novel ovarian carcinoma antigen

HFU Veenstra MSc , CE Fick Dip Clin Path , RH Laeng MD , B Bloch MBChB MMED FRCOG , EB Dowdle MD FRCP

Enhanced therapeutic effect by tumor irradiation followed by immunotherapy in renal cell carcinoma

GG Hillman PhD, RL Maughan PhD, JD Forman MD, GP Haas MD

NK immunorestoration in cancer patients by MRN-100, an iron based compound derived from bivalent and tervalent ferrate

M. Ghoneum PhD

Successful adoptive immunotherapy of murine nonimmunogenic tumor with specific effector cells generated from gene-modified tumor-primed lymph node cells

K Ito MD, H Yoshizawa MD, H Tanaka MD, H Kagamu MD, E Suzuki MD and M Arakawa MD

Alpha interferon prevents hepatocellular carcinoma in responders with HCV-associated hepatic cirrhosis

E Accogli MD, G Mazzella MD, S Sottili BSc, A Colecchia MD, D Festi MD, F Jaboli MD, AM Ciriaci MD, E Roda MD

Reduction of immunogenicity of lectin by poly-ethylene glycol in relation to cytotoxicity towards tumor cells

T Ueno MSc, Y Kimoto MD, K Sakurai PhD, Y Kodera PhD, M Hiroto MSc, A Matsushima PhD, H Nishimura PhD, Y Inada PhD

Treatment of vaginal intraepithelial neoplasia (VAIN) with Interferon α-2a , CO2 laser vaporisation and isotretinoin

E Cardamakis MD, G Kourounis MD, D Dimopoulos MD , M Avaraki MD , P Ginopoulos MD, E Stathopoulos MD , A Diamantis MD , A Pappas MD , H Mantou